The British Journal of Psychiatry (2006) 188: 202-203. doi: 10.1192/bjp.bp.105.012963
© 2006 The Royal College of Psychiatrists
Painful symptoms in depression: under-recognised and under-treated?
ROBERT PEVELER, DPhil, FRCPsych
Mental Health Group, University of Southampton, Southampton
CORNELIUS KATONA, MD, FRCPsych
Kent Institute of Medicine and Health Sciences, University of Kent,
Canterbury
SIMON WESSELY, MD, FRCPsych
Department of Psychological Medicine, Kings College Hospital,
London
CHRISTOPHER DOWRICK, MD, FRCGP
Department of Primary Medical Care, University of Liverpool, Liverpool,
UK
Correspondence:
Professor Robert Peveler, Mental Health Group, University of Southampton,
Royal South Hants Hospital, Southampton SO14 0YG, UK. Tel: +44 (0) 2380
825533; fax: +44 (0) 2380 234243; e-mail:
R.C.Peveler{at}soton.ac.uk
Declaration of interest All of the authors were involved in the
development of a review on depression and pain which was funded by Eli Lilly
and Boehringer Ingelheim. However, the supporting companies were not
represented at meetings and played no part in selecting the participants or
preparing the report or this editorial. R.P. and C.K. have received speaker
fees, hospitality or consultancy fees from Eli Lilly, Wyeth, Lundbeck, Novo
Nordisk and Bristol Myers Squibb. S.W. has received support for conference
attendance from Eli Lilly.

ABSTRACT
Current diagnostic systems maintain an artificial division between
physicaland psychologicaldisorders.
This is
exemplified by the way in which pain symptoms are dealt
with in the context of
depressive illness. The consequences
of this are discussed, and ways to
enhance the clinical care
of patients with depression and pain are
suggested.

INTRODUCTION
Psychiatric training is based on the tacit assumption that the
clinical
focus of psychiatry is on mental disorder.
To that end,
diagnostic practice has been guided by the development
of ICD10
(
World Health Organization,
1992) and DSMIV
(
American Psychiatric Association,
1994). It is therefore
not surprising that many psychiatrists are
only dimly aware
of the deep Cartesian dualism inherent in this approach, and
of its potential adverse consequences for patients. In reality,
the subjective
experience of illness is not easily carved into
separate mental
and physical domains,
and diagnostic practice that is based upon
such dualism cannot
do justice to the complexity of the individual experience
of
what is conventionally regarded as mental illness.
A clear example is seen in the classification of depressive disorders.
There is an intimate relationship between experiences that are conventionally
regarded as psychological symptoms of depressive illness, and
other subjective experiences, such as pain or fatigue, which are regarded as
possible symptoms of physical illness. Some would even attempt to divide pain
and fatigue symptoms themselves into mental and physical subtypes.
ICD and DSM do partly acknowledge the problem. In the chapter on mood
disorders in ICD10 it is stated that:
The relationship between aetiology, symptoms, underlying biochemical
processes, response to treatment and outcome of mood disorders is not yet
sufficiently well understood to allow their classification in a way that is
likely to meet with universal approval.
However, it is then stated that the fundamental disturbance is a
change in mood or affect and that most other symptoms are either
secondary to or easily understood in the context of such changes. What
is not stated is that this is a matter of convention rather than of
fact. Similarly, DSMIV acknowledges that physical symptoms are reported
by patients, but again such symptoms are excluded from the list of diagnostic
features. This is surprising, as the evidence for the association of
depression and pain symptoms is overwhelming. This evidence comes mainly from
epidemiological studies, but recent developments in neuroscience are also
beginning to highlight common mechanisms underlying pain and depression
(Von Knorring & Ekselius,
1994).
A recent review of published literature on pain and depression
(Katona et al, 2005)
highlights these shortcomings and draws the following conclusions.
- Interpretation of research on pain and depression is hampered by a lack of
clear terminology.
- Between two-fifths and two-thirds of patients with depression have painful
symptoms. This is four times higher than the incidence of such symptoms in
individuals without depression. Pain was reported by 54% of psychiatric
in-patients in a Swedish study (Von
Knorring et al, 1984).
- Depression and pain may share common pathogenic pathways, possibly
involving serotonin (Blier & Abbott,
2001). They are associated with the same range of predisposing
environmental factors and early childhood experiences, and may be perpetuated
by similar cognitive processes (Gilmer
& McKinney, 2003).
- The presence of pain may be associated with a poor response to treatment
for depression, and with greater costs of care
(Greenberg et al,
2003).
- The presence of residual symptoms, including pain, is a strong predictor of
early relapse in patients with major depression.
- Doctors may contribute to increased use of resources by pursuing
unnecessary investigations into the cause of depression-related pain.
- Tricyclic antidepressants such as amitriptyline are effective, and probably
more so than selective serotonin reuptake inhibitors (SSRIs), in the treatment
of pain. Serotonin and noradrenaline reuptake inhibitors (SNRIs) such as
venlafaxine and duloxetine may also be more effective than SSRIs in reducing
pain symptoms in patients with depression
(Bair et al,
2004).

TERMINOLOGY AND CLASSIFICATION
Pain in patients with depressive disorders is frequently regarded
as
medically unexplained. A joint report from
the Royal College of
Physicians & Royal College of Psychiatrists
(
2003) notes that the
management of patients with such symptoms
is often inadequate. The report also
states that it is unhelpful
to think of these symptoms in either purely
physical or purely
psychiatric terms, and points out that the phrase
medically
unexplained may be unhelpful and resented by patients.
The traditional classification of diagnoses as either organic
or
psychological, and the use of terms such as functional,
unexplained and psychosomatic to
describe painful
symptoms, are also unhelpful. For most pain
sufferers, such terms generate
frustration and distress and
offer few pointers towards treatment,
evidence-based or otherwise
(
Feinmann &
Newton-John, 2004).

CLINICAL ASSESSMENT
As many patients with depression suffer from pain of some kind,
and in the
light of the extensive evidence that such painful
symptoms have an adverse
effect on clinical outcome, psychiatrists
should enquire about and pay
attention to pain symptoms in
patients who are diagnosed with depression. It
is important
to remember that chronic pain is an important independent risk
factor for self-harm and suicide (
Fishbain,
1999). We should
also take into account any change in pain
symptoms (and their
impact) when assessing patients progress.

PRINCIPLES OF MANAGEMENT
Patients with complex problems often struggle to convey the
reality of
their symptoms. Psychiatrists may consider that
they lack the specialist
knowledge and skills necessary to
treat patients with depression and pain.
Taking patients
pain seriously may therefore be therapeutic in its own
right.
The unstated assumption that physical symptoms are secondary
to
depression may hamper efforts both to engage the patient
and to make
reciprocal links between physical and psychological
factors (as opposed to the
unidirectional links that psychiatrists
may prefer).
Techniques that have proved effective in the neutral space of
primary care can be grouped under the following four headings:
- helping the patient to feel understood (listening, taking physical
complaints seriously, picking up cues of emotional distress, and exploring the
patients concerns about their illness)
- broadening the agenda (opening up the consultation to a discussion of both
physical and psychosocial issues)
- making links (providing explanatory models of the ways in which physical
and psychosocial problems may be linked)
- negotiating treatment (exploring concerns about treatment, including any
side-effects that might be experienced).
Patients who are referred to specialist pain clinics are likely to receive
multimodal, multidisciplinary interventions of demonstrated efficacy. Patients
with depressive disorders who are referred for psychiatric treatment are, in
contrast, much less likely to be managed by an integrated biopsychosocial
approach. Indeed their pain symptoms may even be ignored, on the basis that
they will disappear if only the underlying depression can be
treated effectively. Although it remains difficult so long as psychiatric
services are deeply separated from mainstream medical and surgical services,
more joint work in this area is clearly needed.

CONCLUSIONS
Pain in patients with depressive disorders has received inadequate
attention in terms of both research and treatment. This topic
represents an
important gap in psychiatric training. Many psychiatrists
feel poorly equipped
to manage patients with complex presentations
such as depression and pain, and
may look to colleagues in
the specialty of liaison psychiatry for assistance.
Although
such specialists may have a role in education and training,
depression with pain occurs too frequently for it to be exclusively
their
domain. Twenty-first-century psychiatrists must move
away from the dualism
that currently besets Western medical
practice if their patients are to
receive optimal care.

ACKNOWLEDGMENTS
We thank Charlotte Feinmann, Linda Gask, Huw Lloyd, Amanda C.
de C.
Williams and Liz Wager for their contributions to the
review on depression and
pain and the subsequent discussions
which provided the stimulus for this
editorial.

REFERENCES
- American Psychiatric Association (1994)
Diagnostic and Statistical Manual of Mental Disorders
(4th edn) (DSMIV). Washington, DC: APA.
- Bair, M. J., Robinson, R. L., Eckert, G. J., et al
(2004) Impact of pain on depression treatment response in
primary care. Psychosomatic Medicine,
66, 17
22.[Abstract/Free Full Text]
- Blier, P. & Abbott, F.V. (2001) Putative
mechanisms of action of antidepressant drugs in affective and anxiety
disorders and pain. Journal of Psychiatry and
Neuroscience, 26, 37
43.[Medline]
- Feinmann, C. & Newton-John, T. (2004)
Psychiatric and related management considerations associated with nerve damage
and neuropathic trigeminal pain. Journal of Orofacial
Pain, 18, 360
365.[Medline]
- Fishbain, D. A. (1999) The association of
chronic pain and suicide. Seminars in Clinical
Neuropsychiatry, 4, 221
227.[Medline]
- Gilmer, Gilmer, W. & McKinney, W.T. (2003)
Early experience and depressive disorders: human and non-human primate
studies. Journal of Affective Disorders,
75, 97
113.[CrossRef][Medline]
- Greenberg, P. E., Leong, S. A., Birnbaum, H. G., et al
(2003) The economic burden of depression with painful
symptoms. Journal of Clinical Psychiatry,
64, 17
23.
- Katona, C., Peveler, R., Dowrick, C., et al
(2005) Pain symptoms in depression: definition and clinical
significance. Clinical Medicine,
5, 390
395.[Medline]
- Royal College of Physicians & Royal College of Psychiatrists
(2003) The Psychological Care of Medical Patients. A Practical
Guide. London: Royal College of Physicians/Royal College of
Psychiatrists.
http://www.rcpsych.ac.uk/publications/cr/council/cr108.pdf
- Von Knorring, L. & Ekselius, L. (1994)
Idiopathic pain and depression. Quality of Life
Research, 3, S57
S68.
- Von Knorring, L., Perris, C., Oreland, L., et al
(1984) Pain as a symptom in depressive disorders and its
relationship to platelet monoamine oxidase activity. Journal of
Neural Transmission, 60, 1
9.[Medline]
- World Health Organization (1992) The
ICD10 Classification of Mental and Behavioural Disorders: Clinical
Descriptions and Diagnostic Guidelines. Geneva: WHO.
Received for publication May 5, 2005.
Revision received August 24, 2005.
Accepted for publication September 30, 2005.
Related articles in BJP:
- Highlights of this issue
- SUKHWINDER S. SHERGILL
BJP 2006 188: 199-a9.
[Full Text]